Quintiles Global Commercial Solutions opens in Brazil

Thursday, July 19, 2012 02:36 PM

To help biopharmaceutical companies enter the rapidly growing Brazilian biopharmaceutical market, Quintiles has opened its Global Commercial Solutions business in Brazil, offering customized sales forces, market penetration strategies and product solutions.

The move into Brazil is part of Quintiles' strategy to help biopharma companies expand into growing emerging markets while managing costs and risk. Quintiles recently expanded the business into Russia and into the Middle East and North Africa (MENA) region. Brazil is the world's fifth most populous country, with a population of about 205 million and a biopharmaceutical market valued at $17.1 billion.

Leading the business in Brazil will be general manager Vera Valente, based in Sao Paulo. Most recently, Valente was a director at Interfarma (the Brazilian Pharmaceutical Research Companies Association), where she was responsible for the innovation program and the market access group.

"Brazil is an increasingly important and growing commercial market, and we're eager to help our customers enter this market in a way that manages risks and increases the probability of success," said James Featherstone, senior vice president of global commercial solutions for Quintiles.

"Brazil undoubtedly represents a huge untapped opportunity for the biopharmaceutical industry,” said Valente. “However, as with any new market, there are challenges.”

 

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

August 25

Verizon Communications enters clinical trial space with technology, network, and cloud and data services

Sponsors look to the power of genomic profiling to screen, enroll patients in trials for targeted therapies

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

August

Reality of costs and impact rain on Sunshine Act
Concerns mount over compliance burden on CROs, sponsors, unanticipated consequences for research

Cloud computing expanding into all areas of clinical trial conduct
Benefits outweigh the complexities, challenges of finding right vendors

Already a subscriber?
Log in to your digital subscription.

Purchase the August issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

July

IRB market consolidating rapidly
Private equity driving a new commercial ethical review landscape

Lessons learned from medical device trials
Smaller, faster, more flexible trials hold important insights for pharmaceutical innovation

Already a subscriber?
Log in to your digital subscription.

Purchase the July issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs